Windlas Biotech Limited (WINDLAS) — Cash Flow Reinvestment Rate
Windlas Biotech Limited (WINDLAS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs67.78 Million. Check Windlas Biotech Limited (WINDLAS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Windlas Biotech Limited Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Windlas Biotech Limited across 8 annual periods. Explore how well can Windlas Biotech Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Windlas Biotech Limited (2018–2025)
Year-by-year capital reinvestment analysis for Windlas Biotech Limited. For live market cap and broader valuation context, see WINDLAS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.85x | Rs1.26 Billion | Rs681.87 Million | Rs521.94 Million | ▲ +55.5% |
| 2024 | 1.19x | Rs1.30 Billion | Rs1.09 Billion | Rs376.84 Million | ▼ -14.6% |
| 2023 | 1.39x | Rs850.00 Million | Rs609.65 Million | Rs708.90 Million | ▼ -91.9% |
| 2022 | 17.22x | Rs1.57 Billion | Rs91.30 Million | Rs148.04 Million | ▲ +111.4% |
| 2021 | 8.15x | Rs933.19 Million | Rs114.54 Million | Rs58.47 Million | ▲ +1227.6% |
| 2020 | 0.61x | Rs153.46 Million | Rs250.06 Million | Rs153.10 Million | ▼ -5.3% |
| 2019 | 0.65x | Rs120.83 Million | Rs186.54 Million | Rs89.54 Million | ▼ -51.6% |
| 2018 | 1.34x | Rs395.65 Million | Rs295.91 Million | Rs257.82 Million | — |